208 participants
Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE )
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-05-27
- Start Date:
- 2020-04-27
- Completion:
- 2021-03-30
Conditions
- COVID
Interventions
- BIOLOGICAL
- OTHER
No Results Yet